137 related articles for article (PubMed ID: 33714286)
1. Astragaloside IV attenuates TGF-β-mediated epithelial-mesenchymal transition of pulmonary fibrosis via suppressing NLRP3 expression
Hou Y; Zhen Y; Xue Q; Wang W
Pharmazie; 2021 Feb; 76(2):97-102. PubMed ID: 33714286
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
3. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W
Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
[TBL] [Abstract][Full Text] [Related]
5. 1α,25-dihydroxyvitamin D3 Attenuates TGF-β-Induced Pro-Fibrotic Effects in Human Lung Epithelial Cells through Inhibition of Epithelial-Mesenchymal Transition.
Jiang F; Yang Y; Xue L; Li B; Zhang Z
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28878195
[TBL] [Abstract][Full Text] [Related]
6. Effects of Astragaloside IV Against the TGF-β1-Induced Epithelial-to-Mesenchymal Transition in Peritoneal Mesothelial Cells by Promoting Smad 7 Expression.
Zhang L; Li Z; He W; Xu L; Wang J; Shi J; Sheng M
Cell Physiol Biochem; 2015; 37(1):43-54. PubMed ID: 26278416
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway.
Qian W; Cai X; Qian Q; Zhuang Q; Yang W; Zhang X; Zhao L
Drug Des Devel Ther; 2019; 13():2579-2589. PubMed ID: 31440038
[No Abstract] [Full Text] [Related]
9. Mushroom Inonotus sanghuang alleviates experimental pulmonary fibrosis: Implications for therapy of pulmonary fibrosis.
Su X; Liu K; Xie Y; Zhang M; Wu X; Zhang Y; Wang J
Biomed Pharmacother; 2021 Jan; 133():110919. PubMed ID: 33202282
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells.
Wang YN; Zhao SL; Su YY; Feng JX; Wang S; Liao XM; Wang LN; Li JC; Meng P; Li HY; Zhang YF
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515466
[TBL] [Abstract][Full Text] [Related]
11. Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells.
Feng H; Lu JJ; Wang Y; Pei L; Chen X
Cell Adh Migr; 2017 Sep; 11(5-6):464-475. PubMed ID: 28146373
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
Divya T; Velavan B; Sudhandiran G
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV restrains pulmonary fibrosis progression via the circ_0008898/miR-211-5p/HMGB1 axis.
Zhu M; Zhao L; Zhang X; Zhao R
Chem Biol Drug Des; 2024 Mar; 103(3):e14508. PubMed ID: 38514749
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis.
Tian R; Zhu Y; Yao J; Meng X; Wang J; Xie H; Wang R
Exp Cell Res; 2017 Aug; 357(2):328-334. PubMed ID: 28591554
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV inhibits epithelial-mesenchymal transition and pulmonary fibrosis via lncRNA-ATB/miR-200c/ZEB1 signaling pathway.
Guan Y; Zhang J; Cai X; Cai Y; Song Z; Huang Y; Qian W; Pan Z; Zhang X
Gene; 2024 Mar; 897():148040. PubMed ID: 38065426
[TBL] [Abstract][Full Text] [Related]
16. Metastasis-associated protein 1 promotes epithelial-mesenchymal transition in idiopathic pulmonary fibrosis by up-regulating Snail expression.
Qian W; Cai X; Qian Q; Zhang W; Tian L
J Cell Mol Med; 2020 Jun; 24(11):5998-6007. PubMed ID: 32187849
[TBL] [Abstract][Full Text] [Related]
17. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
18. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
19. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells.
Zhu J; Wen K
Phytother Res; 2018 Jul; 32(7):1289-1296. PubMed ID: 29480652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
